Within ten minutes after placing a phone call to say I was attending a Philadelphia conference for pharmaceutical marketing professionals who want to jump on the social media bandwagon, an electronic version of the childhood game "telephone" was in full swing. Bloggers at the conference posted notes online that a reporter was on her way; word got to people who were attending the conference via Twitter; and as I picked up my coat to leave my office the phone rang—someone at a company in Delaware wanted to learn more about my article.
That's precisely the viral, word-of-mouth power of online social networking media that pharmaceutical companies want to be more a part of. Some of the most popular networking sites include Facebook, Twitter, and LinkedIn, totaling millions of users—and potentially, millions of customers.
AstraZeneca launched a YouTube channel featuring testimonials from real users (not actors) about its ...
